Content area
Full text
About the Authors:
Ruth D. Ellis
* E-mail: [email protected]
Affiliation: Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America
Laura B. Martin
Current address: Novartis Vaccines Institute for Global Health, Siena, Italy
Affiliation: Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America
Donna Shaffer
Affiliation: Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
Carole A. Long
Affiliation: Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America
Kazutoyo Miura
Affiliation: Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America
Michael P. Fay
Affiliation: Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America
David L. Narum
Affiliation: Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America
Daming Zhu
Affiliation: Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America
Gregory E. D. Mullen
Current address: The Rayne Institute, Division of Imaging Sciences, School of Medicine, King's College London, United Kingdom
Affiliation: Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America
Siddhartha Mahanty
Current address: Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Maryland, United States of America
Affiliation: Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America
Louis H. Miller
Affiliation: Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America
Anna P. Durbin
Affiliation: Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
Introduction
The P. falciparum parasite is responsible for at least 300 million acute cases of malaria each year, with an estimated 1 million deaths, most in children in Africa [1]. Morbidity and mortality caused by malaria also have significant direct and indirect effects on the economic development of...